Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Helzlsouer

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Journal of the National Cancer Institute|September 2, 1999
Bad news/good news: information about breast cancer risk following prophylactic oophorectomyK J Helzlsouer
Cancer Research|April 1, 1994
Serological markers of cancer and their applications in clinical trialsK J Helzlsouer
Seminars in Oncology|September 1, 1983
Selenium and cancer preventionK J Helzlsouer
Current Opinion in Oncology|November 1, 1994
Epidemiology, prevention, and early detection of breast cancerK J Helzlsouer
Current Opinion in Oncology|November 1, 1993
Epidemiology, early detection, and prevention of breast cancerK J Helzlsouer
Science (New York, N.Y.)|November 12, 1993
Markers of diseaseK J Helzlsouer
Current Opinion in Oncology|November 1, 1995
Epidemiology, prevention, and early detection of breast cancerK J Helzlsouer
Journal of the National Cancer Institute|December 21, 1994
More on endometrial cancer and tamoxifenK J Helzlsouer, T Bush
Cancer|November 15, 1995
Hormones and breast cancerK J Helzlsouer, R Couzi
Preventive Medicine|September 1, 1993
Cancer chemoprotection by oltipraz: experimental and clinical considerationsK J Helzlsouer, T W Kensler
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|September 2, 1999
Bad news/good news: information about breast cancer risk following prophylactic oophorectomyK J Helzlsouer
Cancer Research|April 1, 1994
Serological markers of cancer and their applications in clinical trialsK J Helzlsouer
Seminars in Oncology|September 1, 1983
Selenium and cancer preventionK J Helzlsouer
Current Opinion in Oncology|November 1, 1994
Epidemiology, prevention, and early detection of breast cancerK J Helzlsouer
Current Opinion in Oncology|November 1, 1993
Epidemiology, early detection, and prevention of breast cancerK J Helzlsouer
Science (New York, N.Y.)|November 12, 1993
Markers of diseaseK J Helzlsouer
Current Opinion in Oncology|November 1, 1995
Epidemiology, prevention, and early detection of breast cancerK J Helzlsouer
Journal of the National Cancer Institute|December 21, 1994
More on endometrial cancer and tamoxifenK J Helzlsouer, T Bush
Cancer|November 15, 1995
Hormones and breast cancerK J Helzlsouer, R Couzi
Preventive Medicine|September 1, 1993
Cancer chemoprotection by oltipraz: experimental and clinical considerationsK J Helzlsouer, T W Kensler
Pageof 10